N/A
Manufactured by Adamas Pharma, LLC
34,976 FDA adverse event reports analyzed
Last updated: 2026-04-14
AMANTADINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Adamas Pharma, LLC. The most commonly reported adverse reactions for AMANTADINE include FALL, HALLUCINATION, DRUG INEFFECTIVE, FATIGUE, DYSKINESIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMANTADINE.
Out of 14,720 classified reports for AMANTADINE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 34,976 FDA FAERS reports that mention AMANTADINE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FALL, HALLUCINATION, DRUG INEFFECTIVE, FATIGUE, DYSKINESIA, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Adamas Pharma, LLC in connection with AMANTADINE. Always verify the specific product and NDC with your pharmacist.